Ginsenoside Rh2 induces cell cycle arrest and differentiation in human leukemia cells by upregulating TGF-β expression

Carcinogenesis

Volumn 34, Issue 2, 2013, Pages 331-340

  Chung, Kyung Sook ^a   Cho, Sung Hee ^a   Shin, Ji Sun ^a,b   Kim, Dong Hyun ^a   Choi, Jung Hye ^c   Choi, Sang Y ^d   Rhee, Young K ^d   Hong, Hee Do ^d   Lee, Kyung Tae ^a  

^a Department of Pharmaceutical Biochemistry ^*  (South Korea)

^b Biomedical Science Institute   (South Korea)

^c Kyung Hee University   (South Korea)

^d Korea Food Research Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN D2; CYCLIN D3; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E; GINSENOSIDE RH 2; MEMBRANE ANTIGEN; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN EXPRESSION; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HL 60; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; UPREGULATION;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUGS, CHINESE HERBAL; G1 PHASE; GINSENOSIDES; HUMANS; IMMUNOPRECIPITATION; LEUKEMIA; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 84873551762     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs341     Document Type: Article

References (39)

1. Lapenna,S. et al. (2009) Cell cycle kinases as therapeutic targets for cancer. Nat. Rev. Drug Discov., 8, 547-566.
2. Giacinti,C. et al. (2006) RB and cell cycle progression. Oncogene, 25, 5220-5227.
3. Sagrario,O. et al. (2002) Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta, 1602, 73-87.
4. Drexler,H.G. et al. (1995) Leukemia cell lines: in vitro models for the study of acute promyelocytic leukemia. Leuk. Res., 19, 681-691.
5. Andersson,G. et al. (1996) Adhesion of human myelomonocytic (HL-60) cells induced by 1,25-dihydroxyvitamin D3 and phorbol myristate acetate is dependent on osteopontin synthesis and the alpha v beta 3 integrin. Connect. Tissue Res., 35, 163-171.
6. Söderberg,S.S. et al. (2009) Complex and context dependent regulation of hematopoiesis by TGF-beta superfamily signaling. Ann. N. Y. Acad. Sci., 1176, 55-69.
7. Hamid,R. et al. (2009) Transforming growth-interacting factor (TGIF) regulates proliferation and differentiation of human myeloid leukemia cells. Mol. Oncol., 3, 451-463.
8. Soucek,K. et al. (2006) Transforming growth factor-beta1 inhibits all-trans retinoic acid-induced apoptosis. Leuk. Res., 30, 607-623.
9. Zimber,A. et al. (2000) Functional interactions between bile acids, all-trans retinoic acid, and 1,25-dihydroxy-vitamin D3 on monocytic differentiation and myeloblastin gene down-regulation in HL60 and THP-1 human leukemia cells. Cancer Res., 60, 672-678.
10. Kim,S.H. et al. (2006) Enhancing effect of indirubin derivatives on 1,25-dihydroxyvitamin D3- and all-trans retinoic acid-induced differentiation of HL-60 leukemia cells. Bioorg. Med. Chem., 14, 6752-6758.
11. Cheng,C.C. et al. (2005) Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Cancer Chemother. Pharmacol., 55, 531-540.
12. Choi,S. et al. (2009) Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1-dependent inhibition of cyclin-dependent kinases. Pharm. Res., 26, 2280-2288.
13. Li,B. et al. (2011) Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Lett., 301, 185-192.
14. Kim,Y.S. et al. (2004) Ginsenoside Rh2 induces apoptosis via activation of caspase-1 and -3 and up-regulation of Bax in human neuroblastoma. Arch. Pharm. Res., 27, 834-839.
15. Kim,H.S. et al. (2004) Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch. Pharm. Res., 27, 429-435.
16. Kim,S.Y. et al. (2007) Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells. Biochem. Pharmacol., 74, 1642-1651.
17. Plumb,J.A. et al. (1989) Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res., 49, 4435-4440.
18. Choi,J.H. et al. (2009) Costunolide-induced apoptosis in human leukemia cells: involvement of c-jun N-terminal kinase activation. Biol. Pharm. Bull., 32, 1803-1808.
19. Shin,J.S. et al. (2010) Sulfuretin isolated from heartwood of Rhus verniciflua inhibits LPS-induced inducible nitric oxide synthase, cyclooxygenase-2, and pro-inflammatory cytokines expression via the down-regulation of NF-kappaB in RAW 264.7 murine macrophage cells. Int. Immunopharmacol., 10, 943-950.
20. Lee,K.W. et al. (2007) Acteoside inhibits human promyelocytic HL-60 leukemia cell proliferation via inducing cell cycle arrest at G0/G1 phase and differentiation into monocyte. Carcinogenesis, 28, 1928-1936.
21. Malumbres,M. et al. (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer, 9, 153-166.
22. Segal,A.W. et al. (1973) The mechanism of the entry of dye into neutrophils in the nitroblue tetrazolium (NBT) test. Clin. Sci. Mol. Med., 45, 817-826.
23. Calnan,D.R. et al. (2008) The FoxO code. Oncogene, 27, 2276-2288.
24. Wang,W. et al. (2007) In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother. Pharmacol., 59, 589-601.
25. Obaya,A.J. et al. (2002) Regulation of cyclin-Cdk activity in mammalian cells. Cell. Mol. Life Sci., 59, 126-142.
26. Malumbres,M. et al. (2007) Cell cycle kinases in cancer. Curr. Opin. Genet. Dev., 17, 60-65.
27. Lee,M.H. et al. (2003) Regulators of G1 cyclin-dependent kinases and cancers. Cancer Metastasis Rev., 22, 435-449.
28. Oh,M. et al. (1999) Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int. J. Oncol., 14, 869-875.
29. Classon,M. et al. (2002) The retinoblastoma tumour suppressor in development and cancer. Nat. Rev. Cancer, 2, 910-917.
30. Cobrinik,D. (2005) Pocket proteins and cell cycle control. Oncogene, 24, 2796-2809.
31. Sherr,C.J. (2004) Principles of tumor suppression. Cell, 116, 235-246.
32. Miura,D. et al. (1999) Antagonistic action of novel 1alpha,25-dihydroxyvitamin D3-26, 23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1alpha,25-dihydroxyvitamin D3. J. Biol. Chem., 274, 16392-16399.
33. Tsiftsoglou,A.S. et al. (2003) Mechanisms involved in the induced differentiation of leukemia cells. Pharmacol. Ther., 100, 257-290.
34. Xia,L.J. et al. (1996) Differentiation of B16 melanoma cells induced by ginsenoside RH2. Yao Xue Xue Bao, 31, 742-745.
35. Kim,Y.S. et al. (1998) Ginsenoside Rh2 and Rh3 induce differentiation of HL-60 cells into granulocytes: modulation of protein kinase C isoforms during differentiation by ginsenoside Rh2. Int. J. Biochem. Cell Biol., 30, 327-338.
36. Lin,H.K. et al. (2005) Deregulated TGF-beta signaling in leukemogenesis. Oncogene, 24, 5693-5700.
37. Keller,J.R. et al. (1991) Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor. Proc. Natl. Acad. Sci. U.S.A., 88, 7190-7194.
38. Jacobsen,S.E. et al. (1991) Transforming growth factor-beta trans-modulates the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines. Blood, 77, 1706-1716.
39. Pardali,K. et al. (2007) Actions of TGF-beta as tumor suppressor and prometastatic factor in human cancer. Biochim. Biophys. Acta, 1775, 21-62.